Prestige Brand Holdings Inc

PBH.US
Healthcare · Drug Manufacturers - Specialty & Generic
51.72
+1.32 (+2.62%)
USD · NYSE

Company Information

Company Name
Prestige Brand Holdings Inc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
ISIN: US74112D1019
CIK: 0001295947
CUSIP: 74112D101
Currency: USD
Full Time Employees: 890
Phone: 914 524 6800
Fiscal Year End: March
IPO Date: Feb 10, 2005
Description:

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Address:

660 White Plains Road, Tarrytown, NY, United States, 10591

People

Directors & Officers

Name Title Year Born
Mr. Ronald M. Lombardi CPA Chairman, President & CEO 1964
Ms. Christine Sacco CPA CFO & COO 1976
Mr. William C. P'Pool J.D. Senior VP, General Counsel & Corporate Secretary 1965
Mr. Adel Mekhail Executive Vice President of Marketing & Sales 1961
Mr. Jeffrey Zerillo Senior Vice President of Operations 1961
Mr. Philip David Terpolilli C.F.A. Director of Investor Relations NA
Dean Siegal Director of Communications NA
Mr. Jose Luis Rosado Senior Vice President of Quality & Regulatory Affairs NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 11, 2026 Jeffrey Zerillo N/A Sale 1.00K $65.93 $65.93K
Dec 01, 2025 Jeffrey Zerillo N/A Sale 281.00 $60.00 $16.86K
Nov 28, 2025 Jeffrey Zerillo N/A Sale 719.00 $60.00 $43.14K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 7.39M Mar 31, 2026 15.60% $0.01 -3.57%
Vanguard Group Inc 5.39M Dec 31, 2025 11.38% $0.00 -1.89%
Ariel Investments, LLC 4.27M Mar 31, 2026 9.02% $2.84 4.19%
Vanguard Portfolio Management, LLC 2.80M Mar 31, 2026 5.92% $0.01 0.00%
Dimensional Fund Advisors, Inc. 2.67M Mar 31, 2026 5.64% $0.03 3.55%
Kayne Anderson Rudnick Investment Management LLC 2.20M Mar 31, 2026 4.65% $0.38 3.04%
Vanguard Capital Management, LLC 2.09M Mar 31, 2026 4.42% $0.00 0.00%
State Street Corp 1.97M Mar 31, 2026 4.16% $0.00 -1.08%
Allspring Global Investments Holdings, LLC 1.56M Mar 31, 2026 3.29% $0.15 -3.43%
Geode Capital Management, LLC 1.46M Mar 31, 2026 3.08% $0.01 1.99%
Morgan Stanley - Brokerage Accounts 1.36M Mar 31, 2026 2.87% $0.00 12.85%
Westwood Holdings Group Inc 1.12M Mar 31, 2026 2.36% $0.48 -5.08%
Delaware Management Holdings Inc 1.07M Mar 31, 2026 2.26% $0.11 -24.72%
Capital Research Global Investors 894.68K Mar 31, 2026 1.89% $0.01 59.34%
Brandes Investment Partners & Co 854.12K Mar 31, 2026 1.80% $0.36 40.77%
Northern Trust Corp 750.31K Mar 31, 2026 1.58% $0.01 2.86%
Charles Schwab Investment Management Inc 742.15K Mar 31, 2026 1.57% $0.01 0.47%
BTIM Corp 643.34K Mar 31, 2026 1.36% $0.31 -9.87%
Nordea Investment Mgmt Bank Demark A/s 599.38K Mar 31, 2026 1.27% $0.03 -2.57%
NORGES BANK 599.02K Dec 31, 2025 1.26% $0.00 14.30%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard High-Yield Corporate Inv 3.76M 7.94% ▲ 0.00% Jun 30, 2026
2 iShares Core S&P Small-Cap ETF 2.85M 6.03% ▲ 0.02% Jun 30, 2026
3 Ariel Fund Investor 1.70M 3.60% ▲ 34.68% Jun 30, 2026
4 Vanguard Total Stock Mkt Idx Inv 1.51M 3.19% ▲ 0.53% Jun 30, 2026
5 iShares Russell 2000 ETF 1.26M 2.65% ▲ 0.60% Jun 30, 2026
6 Vanguard Small Cap Index 1.09M 2.30% ▼ 0.31% Jun 30, 2026
7 Allspring Special Small Cap Value A 812.04K 1.71% ▼ 5.48% Jun 30, 2026
8 Vanguard Small Cap Value Index Inv 690.58K 1.46% ▼ 1.55% Jun 30, 2026
9 FullerThaler Behavioral Small-Cap Value 665.45K 1.40% ▲ 0.00% May 31, 2026
10 DFA US Small Cap Value I 618.07K 1.30% ▲ 4.92% May 31, 2026

Financial Highlights

Market Cap: $2.32B
EBITDA: $340.68M
P/E Ratio: $13.23
PEG Ratio: $1.53
Book Value: $39.89
Earnings/Share: $3.91
Profit Margin: 17.48%
Operating Margin: 26.81%
ROA (TTM): 5.61%
ROE (TTM): 10.23%
Revenue (TTM): $1.09B
Revenue/Share (TTM): $22.47
Earnings Growth (YOY): 12.40%
Revenue Growth (YOY): -5.00%

Valuation Metrics

Enterprise Value: $3.37B
Trailing P/E: 13.23
Forward P/E: 11.22

Shares Statistics

Shares Outstanding: 47.37M
Shares Float: 46.69M
% Insiders: 137.80%
% Institutions: 11,371.10%
Short % Float: 7.86%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$1.09B
Cost of Goods Sold
adjust
$-514.07M
Gross Profit
subtotal
$574.64M
SG&A
adjust
$-116.45M
Other Operating Expense
adjust
$-148.78M
Operating Income
subtotal
$309.41M
Other / Non-Operating Items
adjust
$-119.11M
Net Income
subtotal
$190.30M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PBH.US!